Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Laryngo- Rhino- Otologie ; 101:S335, 2022.
Article in English | EMBASE | ID: covidwho-1967687

ABSTRACT

Background An olfactory disorder is often described as a characteristic initial symptom in patients with COVID-19 infection. The long-term olfactory disorders after a COVID-19 infection have not yet been described in detail. The aim of the study was to investigate the long-term effects of COVID-19 infections on smelling. Methods Patients with persistent, subjective smell &/ taste disorders were examined by means of questionnaires, endoscopic examinations, as well as side-separated olfactory testing using sniffin- sticks (TDI) and taste testing. After initial presentation and initiation of olfactory training, structured controls were performed for 72 patients six, 12 and 18 weeks after initial consultation. Results On average, the patient presented seven months after the onset of symptoms. 70 % of the patients were female and in average patients were 40 years old. Parosmia was reported by 64 % of the patients at this point. An at least unilateral functional anosmia was observed in 24 % and at least unilateral hyposmia in 71 % of the patients. A difference of ≥ 5 points in TDI between the respective sides could be identified in 35 %. During the first (six weeks), second (12 weeks) and third (18 weeks) control 32 %, 9 % and 14 % of the patients showed an improvement in smell of ≥ 5 points in the TDI test using sniffing sticks, respectively. Discussion Persistence of an olfactory disorder in the sense of hyp-/anosmia and parosmia can occur in young, female patients after COVID-19 infection. A side difference in smell can occur due to certain individual anatomy and the entry of the virus. A small proportion of patients with persistent olfactory disorders show regeneration.

2.
Laryngo- Rhino- Otologie ; 101:S335, 2022.
Article in English | EMBASE | ID: covidwho-1967686

ABSTRACT

Background Olfactory and gustatory disorders after COVID-19 vaccination have been described in the literature in case reports. These are mainly described after the Comirnaty vaccination. In this case report, the olfactory and gustatory disorders of two patients after Comirnaty vaccination are described. Methods The two affected patients with persistent subjective olfactory and/ or gustatory dysfunction after COVID-19 vaccination were evaluated using olfactory testing with Sniffin Sticks (TDI) and taste testing. Therapy was subsequently initiated and patients were followed up at regular intervals. Results 2 Patients (1 male and 1 female) with an average age of 80 years, who developed olfactory and/or gustatory disorders after the first and second vaccination respectively, were examined and tested. One case exhibited in the subjective and objective tests a functional anosmia (TDI: right 14.3, left 12.8) whilst the second case displayed hyposmia (TDI: right 18.75, left 21.75) and hypogeusia (right 4/16, left 6/16). Antibody testing showed the presence of IgG(S) but no IgG(Nc) was detected. Discussion Olfactory dysfunction in terms of hyp- or anosmia, as well as parosmia, may occur in patients after COVID-19 vaccination without previous COVID- 19-infection and should always be tested objectively. One case even exhibited hypogeusia. Despite laboratory diagnostics, previous COVID-19 infections cannot be ruled out with certainty. Age-related pre-existing disorders cannot be evaluated. Whether the course of olfactory dysfunction is comparable to that of patients after COVID-19 infection needs to be investigated in further studies.

3.
Medicine (Baltimore) ; 101(20): e29209, 2022 May 20.
Article in English | MEDLINE | ID: covidwho-1860981

ABSTRACT

ABSTRACT: Coronavirus-2019 (COVID-19) emerged in December 2019, causing significant changes in people's social lives and other human activities. The outbreak halted educational activities throughout the world. The Nigerian experience was unique in that most people were skeptical about the pandemic's existence. This practice contributed to the Nigerian people's fear of the COVID-19 outbreak. However, in Nigeria, there has never been a validated or established Covid-19 phobia scale, necessitating this study.This study was a pure validation study on COVID-19 phobia scale (C19PS). The study area was south-east states and a sample of 386 preschool practitioners in urban and rural communities of South East States, Nigeria participated in the study. The eligibility criteria include being a preschool teacher and demonstrating signs of COVID-19 phobia. The validation of the C19PS was done by subjecting the data gathered to principal axis factoring analysis with varimax rotation. The model fit for the data was tested using root mean square error of approximation and comparative fit index.It was found that the Kaiser-Meyer-Olkin value of .845 for the measure of the adequacy of the sample size. There was also a significant Bartlett's test of sphericity (P < .05). This implies that the correlation matrix for the C19PS is not an identity matrix. It was revealed that C19PS had good overall reliability (α = .896) and model fit (Root mean square error of approximation = .042, comparative fit index = .943) in a sample of Nigerian preschool practitioners.As a result, C19PS was recommended as a trustworthy tool for identifying persons who suffer from COVID-19 phobia.


Subject(s)
COVID-19 , Phobic Disorders , COVID-19/diagnosis , COVID-19/epidemiology , Child, Preschool , Humans , Nigeria/epidemiology , Psychometrics , Reproducibility of Results , Rural Population , School Teachers , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL